If I recall correctly, I beleive Rev mentioned on here some time ago that the EMA have never issued a negative opinion for a medical device, however I may be wrong.
Perhaps Rev could enlighten us.
I never bothered to confirm this as I didn't feel it was pertinant given my high expectation that VitroGro® ECM will be approved for sale very shortly.
On my numbers I see this thing going well given each segment of the operation is going to be outsourced to specialised highly qualified and respected contractors. This is going to significantly limit overhead costs and large outlays which would effect working capital. This being said and on my numbers I see TIS becoming cash flow positive in a reasonable time frame.
I expect approval will result in a marked impact on share price and then a steady climb as revenue starts streaming in. By the time FDA approval is through and if you've resisted the urge to sell thats where the big money is to be made. All said and done I expect to TIS to make a pretty penny.
Blip
TIS Price at posting:
22.2¢ Sentiment: Buy Disclosure: Held
